BSE Live
Sep 05, 16:01Prev. Close
1369.90
Open Price
1371.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:58Prev. Close
1370.70
Open Price
1369.10
Bid Price (Qty.)
1372.70 (26)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 4,334.48 | 3,468.98 | 3,088.99 | 3,378.93 | 3,127.20 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 4,334.48 | 3,468.98 | 3,088.99 | 3,378.93 | 3,127.20 | |
Total Operating Revenues | 4,381.92 | 3,497.66 | 3,107.09 | 3,387.24 | 3,153.66 | |
Other Income | 118.81 | 138.26 | 125.35 | 132.68 | 111.91 | |
Total Revenue | 4,500.73 | 3,635.91 | 3,232.44 | 3,519.92 | 3,265.57 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 1,307.98 | 1,087.82 | 938.87 | 1,072.09 | 1,047.32 | |
Purchase Of Stock-In Trade | 825.70 | 376.85 | 260.38 | 282.90 | 307.04 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -126.27 | -101.70 | 14.45 | -36.10 | -107.96 | |
Employee Benefit Expenses | 782.31 | 706.41 | 649.18 | 603.95 | 550.96 | |
Finance Costs | 112.96 | 166.09 | 166.83 | 145.14 | 123.34 | |
Depreciation And Amortisation Expenses | 224.97 | 204.83 | 178.52 | 165.79 | 156.24 | |
Other Expenses | 945.37 | 986.39 | 805.72 | 669.74 | 612.90 | |
Total Expenses | 4,073.02 | 3,426.69 | 3,013.95 | 2,903.50 | 2,689.84 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 427.71 | 209.23 | 218.48 | 616.42 | 575.74 | |
Exceptional Items | 0.00 | -9.32 | -6.15 | 0.00 | -18.29 | |
Profit/Loss Before Tax | 427.71 | 199.91 | 212.34 | 616.42 | 557.45 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 112.71 | 38.58 | 51.05 | 152.62 | 144.29 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -2.13 | 0.50 | -0.83 | 0.89 | -4.15 | |
Tax For Earlier Years | 0.00 | 0.00 | 2.05 | 16.10 | -3.17 | |
Total Tax Expenses | 110.58 | 39.08 | 52.28 | 169.61 | 136.97 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 | |
Profit/Loss From Continuing Operations | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 | |
Profit/Loss For The Period | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 | |
Diluted EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 54.26 | 36.17 | 54.26 | 18.09 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 30.00 | 30.00 | 20.00 | 10.00 | 10.00 |
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
17.07.2025
10.07.2025
07.07.2025
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y
23.05.2025
Emcure Pharmace Standalone March 2025 Net Sales at Rs 1,278.19 crore, up 41.62% Y-o-Y
12.02.2025
Emcure Pharmace Standalone December 2024 Net Sales at Rs 1,028.81 crore, up 18.23% Y-o-Y